Navigation Links
SYNARC Appoints Ciaran Cooper as Vice President, Business Development

SAN FRANCISCO, Feb. 9, 2011 /PRNewswire/ -- SYNARC, the world's leading provider of medical image analysis services to the pharmaceutical and biotechnology industries, announced today that Ciaran Cooper has joined SYNARC to lead the sales and marketing efforts in support of the company's rapidly growing business in imaging services for clinical trials.

Ciaran Cooper, a pioneer in the clinical trials imaging services industry, brings over 20 years experience in medical imaging with an emphasis in business development, strategic planning, and management. He co-founded MIICRO, Inc. in 1994, the first imaging CRO specialized in early phase translational imaging with FDG PET. Since then, Cooper has worked for several imaging core labs as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm thrilled to be joining SYNARC at this exciting time in their development," said Cooper. "SYNARC has always maintained a reputation for science-led, high quality service across a range of therapeutic areas and indications. In the last several years, they have successfully expanded their focus to include oncology and cardiology on top of their historic dominance in musculoskeletal and neurology – few people know how much oncology and cardiology work SYNARC is already engaged in; that's an exciting message to carry out to our customers. To be surrounded by so many bright minds all focused on delivering the highest level of quality to our customers is a dream come true. I'm really proud to be a part of this team."

Aaron Timm, Head of Imaging for CCBR-SYNARC, stated, "Ciaran offers us a very unique perspective on the industry. He has a vast knowledge of the imaging service arena and his reputation for hard work, creativity, and integrity fit well with our team. We're very happy to welcome him aboard."


CCBR-SYNARC's medical image analysis, biochemical marker, and clinical research center services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. CCBR-SYNARC has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical-trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients.  Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today's clinical trials.Media Contact:Joy Valderrama 415 817-8919

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CCBR-SYNARC Expands Electronic Data Capture Capabilities
2. Quark Pharmaceuticals Appoints New Chief Medical Officer
3. West Pharmaceutical Services, Inc. Appoints New Director
4. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
5. Curemark Appoints Preeminent Pediatrics Gastroenterologist
6. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
7. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
8. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
9. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
10. NovaRx Appoints Industry Veteran as President and COO
11. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Post Your Comments:
(Date:11/24/2015)... Diego -based Imprimis Pharmaceuticals, Inc. (NASDAQ: ... development, production and dispensing of novel compounded pharmaceuticals.  ... segments including ophthalmology, urology, sinus and integrative medicine.  ... from four facilities located in California ... New Jersey and Pennsylvania.  For ...
(Date:11/24/2015)... Nov. 24, 2015  Freudenberg Medical has developed specialty tubing ... outside of medical facilities. Africa ... care is sparse. Nevertheless, prompt diagnosis is important to treat ... the virus. With the help of a portable mini-lab or ... to village in affected areas and perform rapid testing for ...
(Date:11/24/2015)... , Nov. 24, 2015   Mast Therapeutics, Inc. ... its molecular adhesion and sealant technology (MAST) platform to ... and stroke, today announced that the Company,s Chief Executive ... the Piper Jaffray 27 th Annual Healthcare Conference ... at the New York Palace hotel in ...
Breaking Medicine Technology:
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... certified to offer their patients the many benefits of the revolutionary BIOLASE WaterLase ... sharp cutting and scraping tools traditionally used by a dentist in Gettysburg, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... launched their Black Friday sale a week early, offering 40% off select bras ... the intimate apparel industry through both mobile fit technology and the latest fashion, ...
(Date:11/24/2015)... ... November 24, 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy ... , FDA has long asserted that design and manufacture of Laboratory Developed ... and do not meet the device regulations. , Come up short in an inspection ...
(Date:11/24/2015)... ... 2015 , ... United Benefit Advisors (UBA), the nation’s leading ... its newest Partner Firm. Based in Jefferson City, Missouri, their core philosophy is ... of whether that client is a business, a family, or an individual. ...
(Date:11/24/2015)... ... November 24, 2015 , ... With Thanksgiving right around the corner, holiday travel ... help protect your family and vehicle. , According to the National Highway Traffic Safety ... Amica is sharing the following safety tips from the NHTSA: , ...
Breaking Medicine News(10 mins):